Literature DB >> 21499858

ADHD in children and adults: diagnosis and prognosis.

Renata Kieling1, Luis A Rohde.   

Abstract

Attention-deficit hyperactivity disorder (ADHD) is one of the most common neuropsychiatric disorders with childhood onset, having a chronic course associated with high dysfunction and morbidity throughout life. Despite significant advances in our understanding of the neurobiological underpinnings of the disorder, diagnosis of ADHD remains strictly clinical and is based on behavioral symptoms of inattention, impulsivity, and hyperactivity. In this chapter, we review the diagnostic process and current controversies in the diagnosis of ADHD, discuss the clinical presentation of the disorder across the lifespan, and examine the patterns of comorbidity and the longitudinal predictors of outcomes. We conclude by pointing out some of the challenges that need to be addressed in future classifications systems to improve the characterization and validity of the diagnosis of ADHD.

Entities:  

Mesh:

Year:  2012        PMID: 21499858     DOI: 10.1007/7854_2010_115

Source DB:  PubMed          Journal:  Curr Top Behav Neurosci        ISSN: 1866-3370


  12 in total

Review 1.  Population Base Rates and Disease Course of Common Psychiatric and Neurodegenerative Disorders.

Authors:  Katherine A Kitchen Andren; Nicolette M Gabel; Julija Stelmokas; Alyson M Rich; Linas A Bieliauskas
Journal:  Neuropsychol Rev       Date:  2017-09-22       Impact factor: 7.444

2.  A quick test of cognitive speed for comparing processing speed to differentiate adult psychiatric referrals with and without attention-deficit/hyperactivity disorders.

Authors:  Elisabeth Hemmersam Wiig; Niels Peter Nielsen
Journal:  Prim Care Companion CNS Disord       Date:  2012-03-29

3.  Diagnosis of children's attention deficit hyperactivity disorder (ADHD) and its association with cytomegalovirus infection with ADHD: a historical review.

Authors:  Rui Zhou; Qun Xia; Huaiyun Shen; Xiaoyun Yang; Yongli Zhang; Jiali Xu
Journal:  Int J Clin Exp Med       Date:  2015-08-15

4.  Adult ADHD: Risk Factor for Dementia or Phenotypic Mimic?

Authors:  Brandy L Callahan; Daniel Bierstone; Donald T Stuss; Sandra E Black
Journal:  Front Aging Neurosci       Date:  2017-08-03       Impact factor: 5.750

5.  Neuronal Intra-Individual Variability Masks Response Selection Differences between ADHD Subtypes-A Need to Change Perspectives.

Authors:  Annet Bluschke; Witold X Chmielewski; Moritz Mückschel; Veit Roessner; Christian Beste
Journal:  Front Hum Neurosci       Date:  2017-06-28       Impact factor: 3.169

6.  Consistency of child self-reports with parent proxy reports on the quality of life of children with attention-deficit/hyperactivity disorder in Riyadh, 2016.

Authors:  Dina M Al-Habib; Fatima A Alhaidar; Ibrahem M Alzayed; Randa M Youssef
Journal:  J Family Community Med       Date:  2019 Jan-Apr

7.  Evidence for an altered architecture and a hierarchical modulation of inhibitory control processes in ADHD.

Authors:  Witold Chmielewski; Annet Bluschke; Benjamin Bodmer; Nicole Wolff; Veit Roessner; Christian Beste
Journal:  Dev Cogn Neurosci       Date:  2019-02-01       Impact factor: 6.464

8.  Association between dopamine D4 receptor polymorphism and age related changes in brain glucose metabolism.

Authors:  Nora D Volkow; Dardo Tomasi; Gene-Jack Wang; Frank Telang; Joanna S Fowler; Rita Z Goldstein; Nelly Klein; Christopher Wong; James M Swanson; Elena Shumay
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

9.  Differences in the performance of NK1R-/- ('knockout') and wildtype mice in the 5‑Choice Continuous Performance Test.

Authors:  Ashley J Porter; Katharine Pillidge; S Clare Stanford; Jared W Young
Journal:  Behav Brain Res       Date:  2015-11-11       Impact factor: 3.332

10.  Neurophysiological mechanisms of interval timing dissociate inattentive and combined ADHD subtypes.

Authors:  Annet Bluschke; Jacqueline Schuster; Veit Roessner; Christian Beste
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.